Not exact matches
Why the drug combination works in resistant CML Why such a combination of the two inhibitor types works in an animal model has now been explained
by Prof. Stephan Grzesiek's team at the Biozentrum of the University of Basel and Dr. Wolfgang Jahnke from Novartis,
by a structural analysis using
nuclear magnetic resonance spectroscopy (NMR).
In developing this idea, the team clarified the distribution of protons and oxygen vacancies in Sc - doped BaZrO3
by combining
nuclear magnetic resonance spectroscopy and thermogravimetric analysis.
He touches on its various isotopes and alludes to their relevance in
nuclear magnetic resonance and Mossbauer
spectroscopy (later covered in detail
by an Essex colleague Brian Fitzsimmons).
Investigations of the fibril specimen
by solid - state
nuclear magnetic resonance spectroscopy provided additional data to build the model and helped to validate the structure.
This was made possible
by a combination of
nuclear magnetic resonance spectroscopy (NMR) and electron paramagnetic
resonance spectroscopy (EPR), two procedures that make it possible to characterise the structural configuration of a protein at atomic resolution.